drugset / Trial / NCT01181141

Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture Surgery

NCT01181141

Phase 3 Completed 92 enrolled Daiichi Sankyo
RandomizedParallel-groupOpen-labelPrevention

Summary

The objective of this study is to evaluate the safety and efficacy of DU-176b compared with enoxaparin sodium for the prevention of venous thromboembolism in patients after elective hip fracture surgery.

Timeline

Start
2008-10
Primary completion
2009-08
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Edoxaban Small molecule 30 mg Oral
Comparator Enoxaparin sodium Other / unclassified 20 mg Subcutaneous